Keywords: highly, pleasing, results, btg, bio-technology, general, achieved
"Highly Pleasing" 1996 Results At BTG
Article | 10 March 1997
Bio-Technology General achieved pretax profits of $10.9 million or $0.23per share in 1996, compared with $3.4 million and $0.08 per share a year earlier. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
